EUVIMEDEUVIMED entdecken
Crossref

Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC

Hongyan Lin, Dongxuan Ai, Qingqing Liu, Xinling Wang, Jiale Gao, Qingqing Chen, Lingyu Ruan, Yuheng Tao, Jian Gao, Liqun Wang iD

Journal of Natural Products · 2023

DOI: 10.1021/acs.jnatprod.3c00384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Natural Products, 2023. Verfasst von Hongyan Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Changzhou University, Changzhou 213164, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Changzhou Science and Technology Bureau, Changzhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a major disease threatening human health worldwide, among which non-small-cell lung cancer (NSCLC) is the most deadly. Clinically, almost all anticancer drugs eventually fail to consistently benefit patients due to serious drug resistance. AKT is a key effector of the PI3K/AKT/mTOR pathway, which is closely related to the occurrence, development, and drug resistance of tumors. Herein, we first designed and synthesized 20 kinds of novel hybrid molecules targeting both tubulin and AKT based on a podophyllotoxin (PPT) skeleton through computer-aided drug design. By CCK8 assay, we screened the compound D1-1 (IC50 = 0.10 μM) with the strongest inhibitory activity against H1975 cells, and its activity was 100 times higher than PPT (IC50 = 12.56 μM) and 300 times higher than gefitinib (IC50 = 32.15 μM). Affinity analysis results showed that D1-1 not only retained the tubulin targeting of PPT but also showed strong AKT targeting. Subsequent pharmacological experiments showed that D1-1 significantly inhibited the proliferation and metastasis of H1975 cells and slightly induced their apoptosis by inhibiting both tubulin polymerization and the AKT pathway activation. Collectively, these data demonstrate that the novel hybrid molecule D1-1 may be an excellent lead compound for the treatment of human NSCLC as a dual inhibitor of tubulin and AKT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsHumansPodophyllotoxinTubulinProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCell Line, TumorPhenylacetatesCell ProliferationDrug Screening Assays, AntitumorApoptosis

Substanzen

PodophyllotoxinTubulinProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesAntineoplastic AgentsPhenylacetatesAKT1 protein, human

Autor:innen und Institutionen

  • School of Pharmacy, Changzhou University, Changzhou 213164, China.
  • State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.
  • School of Medicine, Anhui University of Science and Technology, Huainan 232002, Anhui, China.

ORCID-Profile: Liqun Wang

Förderung

  • National Key Research and Development Program of China
  • Changzhou Science and Technology Bureau
  • Changzhou University

Zitieren

APA

Lin, H., Ai, D., Liu, Q., Wang, X., Gao, J., Chen, Q., Ruan, L., Tao, Y., Gao, J., & Wang, L. (2023). Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.3c00384

Vancouver

Lin H, Ai D, Liu Q, Wang X, Gao J, Chen Q, et al. Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products. 2023. doi:10.1021/acs.jnatprod.3c00384

BibTeX
@article{Lin2023,
  author = {Lin, Hongyan and Ai, Dongxuan and Liu, Qingqing and Wang, Xinling and Gao, Jiale and Chen, Qingqing and Ruan, Lingyu and Tao, Yuheng and Gao, Jian and Wang, Liqun},
  title = {Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC},
  journal = {Journal of Natural Products},
  year = {2023},
  doi = {10.1021/acs.jnatprod.3c00384}
}
Kostenlos starten →